A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation
Nathaniel M. Weathington(University of Alabama at Birmingham), J. Edwin Blalock(Medical University of South Carolina), Brett D. Noerager(University of Alabama at Birmingham), F. Shawn Galin(University of Alabama at Birmingham), Aletta D. Kraneveld(Utrecht University), Gert Folkerts(Utrecht University), Patricia L. Jackson(University of Alabama at Birmingham), Frans P. Nijkamp(Utrecht University), Anneke H. van Houwelingen(Utrecht University)
Cited by 495
Related Papers
Role of TLR4 in the gut-brain axis in Parkinson’s disease: a translational study from men to mice
|Gut|2018|489
Altered gut microbiota and activity in a murine model of autism spectrum disorders
|Brain Behavior and Immunity|2013|436
Exploring Braak’s Hypothesis of Parkinson’s Disease
|Frontiers in Neurology|2017|388
The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice
|Cellular and Molecular Life Sciences|2022|232
Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management
|European Journal of Pharmacology|2011|203